"Finally, the Leronlimab, Ulocuplumab, Burixafor
Post# of 155150
(Total Views: 741)
Posted On: 07/08/2025 4:16:26 PM
"Finally, the Leronlimab, Ulocuplumab, Burixafor, and MSX-122 are promising drugs to treat IS via targeting on CCR5 and CXCR4. In conclusion, our findings suggest that CCR5 and CXCR4 are promising targets for enhancing neuroplasticity post-ischemic stroke, thus providing potentially effective and reliable therapeutic targets for future interventional strategy."
https://www.frontiersin.org/journals/aging-ne...2/abstract
(23)
(0)